VITEK® MS MALDI-TOF system reduces the time to detect microbial contaminants from days to minutes, adding a never-before possible level of safety in the production of many consumer goods.
EMSL Makes the Decision to Implement the bioMérieux VITEK® MS
bioMérieux is Moving Forward to a New Molecular Biology Workflow Solution for Reference or Centralized Laboratories
bioMérieux, a world leader in the field of in vitro diagnostics, has announced that it is moving a new step forward to its comprehensive automation solution dedicated for reference or centralized molecular biology laboratories.
2013 Holiday Schedule
Please be advised of the updated 2013 holiday shipping schedule as we enter the Thanksgiving and Christmas seasons.
bioMérieux Makes a Significant Acquisition in Molecular Biology in the U.S.
With the acquisition of BioFire, bioMérieux consolidates its position as a major player in infectious disease diagnostics.
bioMérieux - First-Half 2013 Results
The Board of Directors of bioMérieux, a world leader in the field of in vitro diagnostics, met on August 30 to approve the consolidated financial statements for the six months ended June 30, 2013.
bioMérieux Announces U.S. FDA Clearance for VITEK MS, a Revolutionary Technology Which Reduces Microbial Identification from Days to Minutes Reinforcing Medical Value of Diagnostics
New Technology made possible by a Nobel Prize Winning discovery holds the promise to improve clinical decision-making for infectious diseases.
bioMérieux - First-Half 2013 Business Review
bioMérieux, a world leader in the field of in vitro diagnostics, today released its business review for the six months ended June 30, 2013.
bioMérieux Partners with Ultimate Labs to Bring Unprecedented Speed to Pathogen Identification for Food, Drug, and Cosmetic Manufacturers
VITEK® MS innovative system reduces the time to detect microbial contaminants from days to minutes, adding a never-before possible level of safety in the production of many consumer goods.
bioMérieux Receives AOAC Official Methods Approval for VIDAS® UP LPT and VIDAS® LMX, Delivering Fast, Sensitive Total Listeria Detection
Fast-tracked, simultaneous AOAC OMA approval of two assays marks the significance of this complete Listeria package.
bioMérieux Receives FDA Approval for THxID®-BRAF Companion Diagnostic Test
The only CE-marked and FDA-approved BRAF test able to simultaneously detect 2 BRAF mutations, V600E and V600K providing high medical value information to select treatment for metastatic melanoma patients.